Acute Respiratory Distress Syndrome (ARDS) Market Research Report By Type (Direct ARDS, Indirect ARDS), By Cause (Pneumonia, Sepsis, Trauma, Aspiration, Pancreatitis, Multiple organ failure), By Severity (Mild, Moderate, Severe), By Treatment (Mechanical ventilation, Positive end expiratory pressure (PEEP), Extracorporeal membrane oxygenation (ECMO), Diuretics, Corticosteroids) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Forecast to 2032

Global Acute Respiratory Distress Syndrome Ards Market Overview

As per MRFR analysis, the Acute Respiratory Distress Syndrome Ards Market Size was estimated at 4.85(USD Billion) in 2022.The Acute Respiratory Distress Syndrome Ards Market Industry is expected to grow from 5.17(USD Billion) in 2023 to 9.2(USD Billion) by 2032. The Acute Respiratory Distress Syndrome Ards Market CAGR (growth rate) is expected to be around 6.62% during the forecast period (2024 - 2032).

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Key Acute Respiratory Distress Syndrome Ards Market Trends Highlighted

The Global Acute Respiratory Distress Syndrome (ARDS) Market is driven by the rising prevalence of respiratory diseases, increased critical care admissions, and advancements in medical technology. The development of novel therapeutic approaches, such as stem cell therapy and extracorporeal membrane oxygenation (ECMO), is expected to create lucrative growth opportunities.Recent trends indicate a shift towards personalized medicine, with tailored treatments based on individual patient characteristics. Moreover, the increased focus on early diagnosis and intervention is expected to improve patient outcomes and reduce healthcare costs. Additionally, the integration of artificial intelligence (AI) and data analytics into ARDS management is expected to enhance precision medicine and improve clinical decision-making.

Acute Respiratory Distress Syndrome Ards Market Drivers

Rising Prevalence of Respiratory Diseases

The increase in respiratory diseases such as pneumonia, sepsis, and trauma is a major driver of the Global Acute Respiratory Distress Syndrome Ards Market Industry. ARDS is a severe lung injury that can complicate these underlying conditions. As respiratory diseases’ frequency continues to escalate, the provision of ARDS treatment and management will also increase. This is beneficial to the Global Acute Respiratory Distress Syndrome Ards Market Industry, as its products and services are essential for taking care of patients with ARDS.

Technological Advancements

Another driver that influences the Global Acute respiratory distress syndrome ards market industry is a technological driver. Due to technological advancement, more and more new treatments are developed to help people who suffer or might suffer from the disease. For example, there is a method called extracorporeal membrane oxygenation. Such a method made it possible to provide support for the organism to the people who would have died previously. So, improving technologies are expected to drive this industry in the future.

Growing Awareness of ARDS

Another driver of this industry is the growing awareness of ARDS. Especially in the past, ARDS is often mistaken for other diseases, or it is underdiagnosed. To reduce the ARDS and to increase awareness over the past years, many public health programs and campaigns and other special initiatives have been taken to provide basic information and also to provide education about this disease. The results of these public awareness programs can be traced in terms of the early onset of this disease, and early treatment of this disease has improved the patient’s condition and increased their survival rates.The Global Acute Respiratory Distress Syndrome Ards Market Industry is expected to expand its profits due to the growing awareness of this disease.

Acute Respiratory Distress Syndrome Ards Market Segment Insights

Acute Respiratory Distress Syndrome Ards Market Type Insights

The Global Acute Respiratory Distress Syndrome Market is divided by Type into immediate ARDS and indirect ARDS. Onset ARDS happens when the lungs are injured directly, and the air sacs fill with liquid during the inammation. This kind of ARDS can be caused by aspiration following a lung disease or a fatality condition such as pneumonia and by inhaling stomach contents, sepsis, chemicals, or other toxic The indirect ARDS is when the lungs are injured by other parts of the body and the reparatory tract to transport fluid into the lungs. Thus, it can result from other illnesses such as ailing or direct infection as severe poisoning following trauma or not directly injuring the lungs.Reports show that immediate ARDS is more common than indirect ARDS, and 60% of the cases of ARDS are immediate. These arise in critically ill people, having a death rate of about 40%. Besides, ARDS is a healthcare burden with an average yearly cost of about $2bn in the US. The need for ARDS medication is expected to gain root in the future due to the increased rate of diseases and new potent medication. The global market for the treatment of ARDS is expected to grow from $1.2 billion in 2019 to $1.5 billion in 2024. There are a number of various ways used in treating ARDS including a breathing machine.Such devices would help care for the lung cells, a supply of extra oxygen used during the process of breathing through a mask, and medication used to reduce constant inflammation and excessive liquid in the lungs. The selection of the medication depends on the intensity of the ARDS infection. Many efforts in both research and development on ways of treating ARDS are ongoing. Such efforts focus on developing medication for lung tissue and other drugs that are seen to improve the functions of the lung and thus the reduction.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Acute Respiratory Distress Syndrome Ards Market Cause Insights

The Global Acute Respiratory Distress Syndrome Market is segmented by cause into pneumonia, sepsis, trauma, aspiration, pancreatitis and multiple organ failure. Among these, sepsis and pneumonia remain the most common causes of ARDS. It can be explained by the growing amount of pneumonia cases and the presence of such underlying comorbidities as immunodeficiency and chronic diseases. Trauma is the third most widespread cause of ARDS and is typical for younger individuals and victims of accidents. Aspirations, pancreatitis and multiple organ failure are less typical for ARDS but may be prevalent among some patient populations.It is crucial to know the ARDS prevalence across the different causes for the creation of the proper and relevant prevention and treatment strategies.

Acute Respiratory Distress Syndrome Ards Market Severity Insights

Severity Segment Insights and Overview: The severity of Acute Respiratory Distress Syndrome (ARDS) plays a crucial role in determining market segmentation and treatment strategies. Based on severity, the Global Acute Respiratory Distress Syndrome (ARDS) Market is segmented into three categories: Mild, Moderate, and Severe. Mild ARDS: In 2023, the Mild ARDS segment accounted for approximately 28.6% of the overall market revenue. Patients with Mild ARDS exhibit relatively less severe symptoms and have a higher survival rate. Treatment typically involves supplemental oxygen and close monitoring.Moderate ARDS: In 2023, the Moderate ARDS segment held a market share of around 42.4%. Patients with Moderate ARDS experience more pronounced respiratory distress and require more intensive care. Non-invasive mechanical ventilation or low levels of positive end-expiratory pressure (PEEP) are commonly used treatments. Severe ARDS: In 2023, the Severe ARDS segment accounted for the largest market share of approximately 29.0%. Patients with Severe ARDS have the most critical symptoms and require invasive mechanical ventilation and high levels of PEEP.Extracorporeal membrane oxygenation (ECMO) may also be necessary in some cases. The Global Acute Respiratory Distress Syndrome (ARDS) Market is projected to witness significant growth in the coming years, driven by factors such as the rising prevalence of respiratory diseases, advancements in medical technology, and increasing awareness about ARDS.

Acute Respiratory Distress Syndrome Ards Market Treatment Insights

The Treatment segment of the Global Acute Respiratory Distress Syndrome (ARDS) Market is anticipated to grow significantly in the coming years. Mechanical ventilation is the primary treatment for ARDS, with Positive End-Expiratory Pressure (PEEP) playing a crucial role in improving oxygenation. Extracorporeal Membrane Oxygenation (ECMO) is utilized in severe cases to provide support to the lungs. Diuretics are administered to manage fluid overload, while Corticosteroids are used to reduce inflammation. The Global ARDS Market revenue for Treatment is projected to reach $2.5 billion by 2025, exhibiting a steady growth rate.Market segmentation offers valuable insights into the different treatment modalities and their contributions to the overall market growth. This data is essential for industry stakeholders to make informed decisions and develop effective strategies that cater to the evolving needs of ARDS patients.

Acute Respiratory Distress Syndrome Ards Market Regional Insights

North America is expected to hold the largest share of the global Acute Respiratory Distress Syndrome (ARDS) market in 2023, owing to the high prevalence of respiratory diseases, well-established healthcare infrastructure, and increasing adoption of advanced treatment modalities. However, Asia Pacific is projected to exhibit the highest growth rate during the forecast period (2023-2032), driven by the rising incidence of ARDS, increasing healthcare expenditure, and expanding access to healthcare services in emerging economies like China and India.Europe holds a significant market share due to the presence of major pharmaceutical companies and research institutions, along with favorable reimbursement policies. South America and the Middle East and Africa (MEA) are expected to witness steady growth, supported by government initiatives to improve healthcare infrastructure and increase awareness about ARDS.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Acute Respiratory Distress Syndrome Ards Market Key Players And Competitive Insights

In the Acute Respiratory Distress Syndrome Ards Market, every major player is striving to increase the competition with the help of some of the other ways. Some of the top Acute Respiratory Distress Syndrome Ards Market players are adopting the method of merger, acquisition, partnership, and collaboration. The same companies invest huge amounts of money only in research and development as they can introduce new technologies and other therapies that can manage Acute Respiratory Distress Syndrome Ards easily. In this scenario, the Acute Respiratory Distress Syndrome Ards Market is highly competitive, and many top leading players are involved and have invested huge amounts and are aiming to share the most significant portions of the market. In the coming years, the market for Acute Respiratory Distress Syndrome Ards Market is expected to remain the same, and it will be competitive in nature.Efforts by prominent Acute Respiratory Distress Syndrome Ards Market competitorA major Acute Respiratory Distress Syndrome Ards Market competitor is that the company has invested huge amounts of money only in different areas to increase its sales or revenue and cater to multiple or multiple needs of the people suffering from the Acute Respiratory Distress Syndrome Ards. This leading company has introduced multiple devices for these patients, such as mechanical ventilators, oxygen therapy devices, and a monitoring system as well. The company has a worldwide presence, and it tries to develop ties with multiple healthcare providers so that patients can get the best quality healthcare services. The company invests huge amounts of money only in research and technology and gives the highest level of care to these patients. The company is also enthusiastic to make such devices or systems through which the effects of the systems can be minimized.

Key Companies in the Acute Respiratory Distress Syndrome Ards Market Include

• Air Liquide


• ResMed


• Draeger


• Hamilton Medical AG


• Getinge


• Evonik Industries


• GE Healthcare


• Smiths Medical


• Vyaire Medical


• Medtronic


• Philips Healthcare


• Linde Healthcare


• Teleflex

Acute Respiratory Distress Syndrome Ards Market Industry Developments

Recent developments in the Global Acute Respiratory Distress Syndrome (ARDS) Market include advancements in treatment options and growing research initiatives. For instance, in 2023, researchers at the University of California, San Francisco, identified a potential new therapeutic target for ARDS, offering hope for more effective treatments in the future. Additionally, several pharmaceutical companies are actively developing new drugs for ARDS, with some candidates currently in clinical trials. These developments indicate a promising future for the ARDS market as new and potentially more effective treatments emerge.

Acute Respiratory Distress Syndrome Ards Market Segmentation Insights

• 
  

  Acute Respiratory Distress Syndrome Ards Market Type Outlook

  
  
  
  
  • Direct ARDS
  
  
  • Indirect ARDS
  
  
  
  

• 
  

  Acute Respiratory Distress Syndrome Ards Market Cause Outlook

  
  
  
  
  • Pneumonia
  
  
  • Sepsis
  
  
  • Trauma
  
  
  • Aspiration
  
  
  • Pancreatitis
  
  
  • Multiple organ failure
  
  
  
  

• 
  

  Acute Respiratory Distress Syndrome Ards Market Severity Outlook

  
  
  
  
  • Mild
  
  
  • Moderate
  
  
  • Severe
  
  
  
  

• 
  

  Acute Respiratory Distress Syndrome Ards Market Treatment Outlook

  
  
  
  
  • Mechanical ventilation
  
  
  • Positive end-expiratory pressure (PEEP)
  
  
  • Extracorporeal membrane oxygenation (ECMO)
  
  
  • Diuretics
  
  
  • Corticosteroids
  
  
  
  

• 
  

  Acute Respiratory Distress Syndrome Ards Market Regional Outlook

  
  
  
  
  • North America
  
  
  • Europe
  
  
  • South America
  
  
  • Asia Pacific
  
  
  • Middle East and Africa